The Boston tech scene was buzzing with funding announcements, innovative breakthroughs and biotech facility news last week. Keep reading to catch up on the latest Boston tech news. This is the Built In Boston Weekly Refresh.
Cognito raised $73M. Cognito is a Cambridge-based startup that developed a wearable headset that may be able to slow the progression of Alzheimer’s disease. The headset has received Breakthrough Device Designation from the FDA. This Series B funding will help Cognito conduct a clinical trial with about 500 patients across the U.S. [Built In Boston]
Butlr secured $5M. Butlr develops hardware and software solutions that can track people’s body temperature to generate real-time data about building occupancy. Companies can use this data to improve their workspace planning and better manage their facilities. Butlr is headquartered in San Francisco, but it has a Boston cohort of about 15 employees. [Built In Boston]
Boston Tech Quote of the Week
“With its location adjacent to Harvard’s growing Allston campus and its introduction of state-of-the-art Class A lab space, 176 Lincoln will be an important addition to the rapidly growing life science, medical, academic research and corporate corridor stretching through Boston and into Cambridge.” — Berkeley Investments President Young Park
City officials approved a real estate development with lab space. The three-building development, called 176 Lincoln, will bring together restaurants, apartments and 720,000 square feet of lab and office space for Boston’s biotech and life sciences companies. The five-acre parcel at 176 Lincoln St. has sat unused for decades. [Built In Boston]
Siobhan Dullea landed a new gig. Dullea, the former CEO of startup accelerator MassChallenge, will become the executive director of Innovate@BU, a Boston University program that educates students about hot topics in innovation and entrepreneurship. The program started five years ago and is available to all undergraduate students at BU. [BostInno]
